These have been successfully applied to routine analyses and benchmarked for productivity increases of 3 to 18 fold. These strategies apply universally throughout pharmaceutical activities and provide increased levels of critical information than has been previously available. The pharmaceutical industry continues to undergo unprecedented change. Organizational initiatives, such as parallel operations and early initiation of projects, have dramatically reduced the time line of product research and development.
Emphasis is focused on enhancement of productivity and shortened time lines.
Thus, we have placed emphasis on the development and implementation of strategies which provide increased levels of analytical information in reduced time periods. This approach has been benchmarked with favorable levels of structure analysis productivity enhancement. With the multiplication of sample generation by combinatorial chemistry techniques our new analytical strategy focuses on MW as the critical element of confirmation for synthetic compounds. This strategy rapidly provides sufficient information for a project to continue without delay. More detailed studies are conducted at a later time if the candidate compound proves to have pharmaceutical activity.